NeonMind Biosciences Inc.

NMDBF · OTC
Analyze with AI
11/30/2022
8/31/2022
5/31/2022
2/28/2022
Assets
Cash & Equivalents$36$17$2$137
Short-Term Investments$34$39$69$150
Receivables$58$145$132$113
Inventory$0$0$0$0
Other Curr. Assets$0$0$0$0
Total Curr. Assets$129$291$388$606
Property Plant & Equip (Net)$0$2$2$2
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$58
Total NC Assets$0$2$2$60
Other Assets$0$0$0$0
Total Assets$129$293$390$665
Liabilities
Payables$677$726$622$609
Short-Term Debt$0$72$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$8$60$37$8
Total Curr. Liab.$684$859$659$617
LT Debt$847$891$890$505
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$847$891$890$505
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$1,531$1,750$1,549$1,122
Equity
Pref Stock$0$0$0$0
Common Stock$8,380$8,247$7,943$7,936
Retained Earnings-$15,123-$14,945-$14,871-$13,970
AOCI$5,299$5,189$5,717$5,557
Other Equity$43$51$51$21
Total Equity-$1,402-$1,457-$1,159-$457
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$129$293$390$665
Net Debt$811$947$887$368